Loading...
Loading...
Holder clone rankings through .
Among the 2 tracked institutional investors we monitor, BLRX (BIOLINE RX LIMITED) is held with a combined value of $93.95K across 30,208 shares. The largest holder is RENAISSANCE TECHNOLOGIES LLC with a position worth $48.09K. 2 funds opened new positions in the most recent quarter.
Total Institutional Value
$93.95K
Total Shares Held
30,208
Institutional Holders
2
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $48.09K | 0.00% | New |
| 2 | CITADEL ADVISORS LLC | $45.87K | 0.00% | New |
As of the latest SEC 13F filings, RENAISSANCE TECHNOLOGIES LLC is the largest institutional holder of BLRX with a position worth $48.09K, representing 0.00% of their portfolio. In total, 2 institutional investors hold BLRX with a combined value of $93.95K.
In the most recent quarter, 2 funds opened a new position in BLRX.
Institutional investors hold $93.95K worth of BLRX stock across 2 positions. The largest institutional holder is RENAISSANCE TECHNOLOGIES LLC with $48.09K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For BLRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
Last Close
$2.06
2026-10-22
YTD
-26.3%
5% of 52-week range